Register for the Fierce Coronavirus Virtual Series
Join us the week of March 30th for a series of virtual updates and expert panels discussing the coronavirus
The data was highly anticipated, especially since the two partners continued testing after the compound missed its endpoints in phase 2 studies.
Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.
Vertex is keeping mum on exact details but, as with the rest of its biopharma peers, is seeing trial disruption due to the COVID-19 pandemic.